{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:31:10Z","timestamp":1791271870890,"version":"4.1.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0196196","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T17:27:46Z","timestamp":1524504466000},"page":"e0196196","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Serum galactomannan antigen as a prognostic and diagnostic marker for invasive aspergillosis in heterogeneous medicine ICU patient population"],"prefix":"10.1371","volume":"13","author":[{"given":"Yubhisha","family":"Dabas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6218-2175","authenticated-orcid":true,"given":"Immaculata","family":"Xess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"key":"ref1","first-page":"e34","article-title":"Epidemiology of invasive aspergillosis and risk factors in non neutropaenic patients","volume":"27","author":"JP Gangneux","year":"2010"},{"key":"ref2","first-page":"1","article-title":"Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes","volume":"19","author":"FS Taccone","year":"2015"},{"key":"ref3","first-page":"156","article-title":"Pulmonary aspergillosis: a clinical review","volume":"20","author":"M Kousha","year":"2011"},{"key":"ref4","first-page":"621","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"170","author":"W Meersseman","year":"2004"},{"key":"ref5","first-page":"284","article-title":"<italic>Aspergillus<\/italic> in the lower respiratory tract of immunocompetent critically ill patients","volume":"69","author":"M Lugosi","year":"2014"},{"key":"ref6","first-page":"27","article-title":"Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients","volume":"177","author":"W Meersseman","year":"2008"},{"key":"ref7","first-page":"322","article-title":"Isolation of <italic>Aspergillus<\/italic> in critically ill patients: a potential marker of poor outcome","volume":"21","author":"F Khasawneh","year":"2006"},{"key":"ref8","first-page":"R191","article-title":"Isolation of <italic>Aspergillus<\/italic> spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome","volume":"9","author":"J Garnacho-Montero","year":"2005"},{"key":"ref9","first-page":"251","article-title":"Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality","volume":"59","author":"K Vandewoude","year":"2004"},{"key":"ref10","first-page":"R31","article-title":"Clinical relevance of <italic>Aspergillus<\/italic> isolation from respiratory tract samples in critically ill patients","volume":"10","author":"KH Vandewoude","year":"2006"},{"key":"ref11","first-page":"1813","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"B De Pauw","year":"2008"},{"key":"ref12","first-page":"56","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"SI Blot","year":"2012"},{"key":"ref13","first-page":"204","article-title":"<italic>Aspergillus<\/italic> infections in the critically ill","volume":"7","author":"R Dutkiewicz","year":"2010"},{"key":"ref14","first-page":"870","article-title":"Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome","volume":"16","author":"J Guinea","year":"2010"},{"key":"ref15","first-page":"178","article-title":"Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients","volume":"19","author":"S Eigl","year":"2015"},{"key":"ref16","first-page":"S125","article-title":"Laboratory detection and identification of <italic>Aspergillus<\/italic> species by microscopic observation and culture: the traditional approach","volume":"43","author":"N McClenny","year":"2005"},{"key":"ref17","first-page":"S132","article-title":"Conventional or molecular measurement of <italic>Aspergillus<\/italic> load","volume":"47","author":"KV Clemons","year":"2009"},{"issue":"4","key":"ref18","first-page":"433","article-title":"Routine processing procedures for isolating filamentous fungi from respiratory sputum samples may underestimate fungal prevalence","volume":"50","author":"CH Pashley","year":"2012"},{"key":"ref19","first-page":"1453","article-title":"Comparison of semi-quantitative endotracheal aspirates to quantitative non-bronchoscopic bronchoalveolar lavage in diagnosing ventilator-associated pneumonia","volume":"54","author":"S Fujitani","year":"2009"},{"key":"ref20","first-page":"29","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"JA Hanley","year":"1982"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-017-4731-2","article-title":"Intensive care medicine research agenda on invasive fungal infection in critically ill patients","author":"M Bassetti","year":"2017"},{"key":"ref22","article-title":"Emerging aspergillosis by azole-resistant <italic>Aspergillus fumigatus<\/italic> at an intensive care unit in the Netherlands, 2010 to 2013","volume":"21","author":"J van Paassen","year":"2016"},{"key":"ref23","first-page":"139","article-title":"Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study","volume":"20","author":"M Schroeder","year":"2016"},{"key":"ref24","first-page":"218","article-title":"Clinical review: International comparisons in critical care\u2014lessons learned","volume":"16","author":"S Murthy","year":"2012"},{"key":"ref25","first-page":"74","article-title":"Serum galactomannan assay for diagnosis of probable invasive Aspergillosis in acute leukemia and hematopoietic stem cell transplantation","volume":"34","author":"I Ghosh","year":"2013"},{"key":"ref26","first-page":"e90176","article-title":"Voriconazole or Amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in Invasive Aspergillosis","volume":"9","author":"LYA Chai","year":"2014"},{"key":"ref27","first-page":"2366","article-title":"False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam","volume":"349","author":"A Sulahian","year":"2003"},{"key":"ref28","first-page":"389","article-title":"Occurrence and kinetics of false-positive <italic>Aspergillus<\/italic> galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders","volume":"44","author":"A Aubry","year":"2006"},{"key":"ref29","first-page":"2199","article-title":"Reduction in false-positive <italic>Aspergillus<\/italic> serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States","volume":"52","author":"P Vergidis","year":"2014"},{"key":"ref30","first-page":"217","article-title":"The interaction between piperacillin\/tazobactam and assays for <italic>Aspergillus<\/italic> galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections","volume":"38","author":"G Metan","year":"2010"},{"key":"ref31","first-page":"10","article-title":"False positive galactomannan Platelia due to piperacillin-tazobactam","volume":"42","author":"MP Gerlinger","year":"2012"},{"key":"ref32","first-page":"1746","article-title":"Piperacillin\/tazobactam (Tazocin) seems to be no longer responsible for false-positive results of the galactomannan assay","volume":"67","author":"M Mikulska","year":"2012"},{"key":"ref33","first-page":"1437","article-title":"Generic piperacillin\/tazobactam is not associated with galactomannan false-positivity in adult patients with cancer: a case\u2013control study","volume":"34","author":"JH Ko","year":"2015"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0196196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T18:45:36Z","timestamp":1588963536000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0196196"}},"subtitle":[],"editor":[{"given":"Chiara","family":"Lazzeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,23]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0196196","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,23]]}}}